SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-11-027084
Filing Date
2011-05-09
Accepted
2011-05-09 08:00:36
Documents
4
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a11-9383_110q.htm 10-Q 830245
2 EX-31.1.1 a11-9383_1ex31d1d1.htm EX-31.1.1 13375
3 EX-31.2.1 a11-9383_1ex31d2d1.htm EX-31.2.1 13838
4 EX-32.1 a11-9383_1ex32d1.htm EX-32.1 6960
  Complete submission text file 0001104659-11-027084.txt   865425
Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 443-545-1819
OSIRIS THERAPEUTICS, INC. (Filer) CIK: 0001360886 (see all company filings)

IRS No.: 710881115 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32966 | Film No.: 11821398
SIC: 2836 Biological Products, (No Diagnostic Substances)